Trial intelligence / Profile preview

Lac5-Nasal: N. lactamica Challenge

NCT04135053Unknown

Sponsor
University of Southampton
Start
Feb 2019
Primary completion
Feb 2020
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Open-label, single-arm trial of Neisseria lactamica in bacterial meningitis, sponsored by University of Southampton. Primary endpoints: Haematology blood results at 1 year, White Cell Count at 1 year and 3 more. Status: unknown.

02

Drugs

Neisseria lactamica
03

Conditions

bacterial meningitis

Beyond the preview

Go deeper on NCT04135053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04135053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call